免疫
生物
细胞生物学
免疫系统
免疫学
树突状细胞
先天免疫系统
获得性免疫系统
细胞免疫
癌症研究
滤泡树突状细胞
淋巴细胞活化
作者
Maria A. Koufaki,Erin Richardson,Eduardo Bonavita,Richard Reeves,Agrin Moeini,Shih‐Chieh Chiang,Antonia Banyard,Massimo Russo,Charles H. Earnshaw,Charlotte R. Bell,Eimear Flanagan,Victoria S. Pelly,Laëtitia Nebot-Bral,Anna Pidoux,Poppy Dunn,Sudhakar Sahoo,Sandrine Henri,Bernard MALISSEN,Andrew S. MacDonald,Natalia Moncaut
出处
期刊:Immunity
[Cell Press]
日期:2026-08-01
卷期号:59 (8): 2282-2298.e10
被引量:8
标识
DOI:10.1016/j.immuni.2026.07.002
摘要
Single-cell transcriptomics identifies a convergent activation state of conventional dendritic cells (cDCs) shared by type 1 and type 2 cDCs (cDC1s and cDC2s). These activated DCs (actDCs) are characterized by co-expression of T cell-stimulating and inhibitory molecules. Here, we examined the functional contribution of actDCs to anti-tumor immunity by developing mouse models that leverage CCR7 expression to conditionally label or ablate actDCs. The capacity of cDCs to stimulate tumor-specific cytotoxic T lymphocytes (CTLs) was restricted to the actDC state. cDC1- and cDC2-derived actDCs supported CTL priming through cross-presentation and cross-dressing, respectively, with the latter occurring in a cancer type-dependent manner. actDCs were required for the activation of naive CTLs in tumor-draining lymph nodes and for sustaining effector CTL function within tumors. Consequently, ablation of actDCs impaired spontaneous tumor control and responses to immune checkpoint blockade or adoptive T cell therapy. Thus, the actDC state emerges as a critical determinant of cDC-mediated anti-tumor immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI